DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 04 · Volume 17 · October 1991 DOI: 10.1055/s-002-7663

  • 317
    Fareed, Jawed:

    Venous Thromboprophylaxis in the 1990s: A Perspective

  • 322
    Arcelus, Juan I.; Caprini, Joseph A.; Traverso, Clara I.:

    International Perspective on Venous Thromboembolism Prophylaxis in Surgery

  • 326
    Toulemonde, Francis; Doutremepuich, Christian:

    Is Pulmonary Embolism a Suitable Evaluation Criterion of the Efficacy of Prophylactic Treatment in Surgery?

  • 332
    Bergqvist, David:

    Current Trends in the Management of Postsurgical Thromboembolism: The Role of Low Molecular Weight Heparin

  • 336
    Breyer, Hans Georg:

    Thromboprophylaxis with Heparin and Low Molecular Weight Heparin in Elective Hip Surgery: Current Status and Perspectives

  • 343
    Wolf, Helmut; Encke, Albrecht; Haas, Sylvia; Welzel, Dieter:

    Comparison of the Efficacy and Safety of Sandoz Low Molecular Weight Heparin and Unfractionated Heparin: Interim Analysis of a Multicenter Trial

  • 347
    Green, David:

    Prevention of Thromboembolism After Spinal Cord Injury

  • 351
    Toulemonde, Francis:

    Can the Bleeding Potential of Low Molecular Weight Heparins be Assessed and Minimized in Postsurgery Prophylaxis?

  • 356
    Caprini, Joseph A.; Arcelus, Juan I.; Traverso, Clara I.; Hasty, James H.:

    Low Molecular Weight Heparins and External Pneumatic Compression as Options for Venous Thromboembolism Prophylaxis: A Surgeon's Perspective

  • 367
    Samama, Charles Marc; Barre, Eric; Combe, Sophie; Dreux, Sophie; Kieffer, Edouard; Viars, Pierre:

    A Pilot Study on the Use of a Low Molecular Weight Heparin (Enoxaparin) in Arterial Reconstructive Surgery

  • 371
    Fields, William S.:

    Heparins and Stroke: Is There a Place for Low Molecular Weight Heparins?

  • 375
    Vinazzer, Helmut:

    Effect of Pentosan Polysulfate on Fibrinolysis: Basic Tests and Clinical Application

  • 379
    Klöcking, Hans-Peter; Hoffmann, Anna; Fareed, Jawed:

    Influence of Hypersulfated Lactobionic Acid Amides on Tissue Plasminogen Activator Release

  • 385
    Vinazzer, Helmut:

    Advantages of Low Molecular Weight Heparin Over Standard Heparin: Facts and Fiction

  • 389
    Fears, Robin; Esmail, Ashiq F.; Greenwood, Helen C.:

    Effect of Heparin on the Fibrinolytic Response to Plasminogen Activators

  • 394
    Losonczy, Hajna; Dávid, Marianna; Nagy, Ibolya:

    Effect of Pentosan Polysulfate on Activated Partial Thromboplastin Time, Thrombin Time, Euglobulin Clot Lysis, and on Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor Activities in Patients with Thromboembolic Disease

  • 399
    Bianchi, Giorgio; Calvani, Angelo Benvenuto; Mantovani, Marisa; Prino, Giuseppe:

    Enhancement by Defibrotide of Prostanoid Neosynthesis from Arachidonic Acid: An Adenosine Receptor-Mediated Effect?

  • 404
    Porta, Roberto; Calvani, Angelo Benvenuto; Pescador, Rodolfo; Mantovani, Marisa; Prino, Giuseppe:

    Absorption Through the Peritoneum of the Macromolecular Profibrinolytic Drug Defibrotide in the Rabbit

  • 407
    Fears, Robin; Standring, Ruth; Abraham, Ralph:

    Fibrinolytic Activity in Patients with Diabetes Mellitus: Characterization of the Effects of Thrombolytic Agents on Plasma Clot Lysis In Vitro

  • 412
    Gram, Jørgen; Jespersen, Jørgen:

    Induction and Possible Role of Fibrinolysis in Diabetes Mellitus

  • 417
    Geiger, Margarethe; Binder, Bernd R.:

    Plasminogen Activation in Diabetes Mellitus: Kinetics of Plasmin Formation with Plasminogen and Tissue Plasminogen Activator from Diabetic Donors

  • 422
    Strano, Antonio; Davì, Giovanni; Patrono, Carlo:

    In Vivo Platelet Activation in Diabetes Mellitus

  • 426
    Cohen, Isaac; Burk, Dan L.; Fullerton, Ruth; Veis, Arthur; Green, David:

    Nonenzymatic Glycation of Platelet Proteins in Diabetic Patients

  • 433
    Tschoepe, D.; Roesen, P.; Esser, J.; Schwippert, B.; Nieuwenhuis, H. K.; Kehrel, B.; Gries, F. A.:

    Large Platelets Circulate in an Activated State in Diabetes Mellitus

  • 439
    Colwell, John A.:

    Clinical Trials of Antiplatelet Agents in Diabetes Mellitus: Rationale and Results

  • 445
    Jude, Brigitte; Fontaine, Pierre:

    Modifications of Monocyte Procoagulant Activity in Diabetes Mellitus

  • 448
    Balas, Panagiotis:

    Diabetic Capillary Angiopathy of the Dermis of the Hand and Foot in Patients with Diabetes Mellitus

  • 450
    Christiansen, Hanne M.; Lassen, Michael R.; Borris, Lars C.; Sørensen, Jens V.; Rahr, Hans B.; Jørgensen, Lars N.; Jørgensen, Peer W.; Hauch, Ole:

    Biologic Tolerance of Two Different Low Molecular Weight Heparins

  • 455
    Fareed, Jawed; Walenga, Jeanine M.; Leya, F.; Bacher, P.; Hoppensteadt, Debra; Messmore, Harry; Pifarre, Roque:

    Some Objective Considerations for the Use of Heparins and Recombinant Hirudin in Percutaneous Transluminal Coronary Angioplasty

  • 471

    Report on the Chicago Satellite Symposia of the Xth International Congress of Fibrinolysis, August 2-4, 1990

  • 477
    Bick, Rodger L.; Murano, Genesio; Samama, Meyer M.; Wenzel, Ernst:

    Abstracts of Current Literature